Pyrimethamine Market to Reach USD 1,650 Million, Globally, by 2030 at 5.0% CAGR: We Market Research
Pyrimethamine Market Outlook 2022-2030:
Pyrimethamine Market Growth size was estimated at USD 1,000 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% to reach approximately USD 1,650 million in 2030. Because pyrimethamine is resistant to many Plasmodium species, it is usually administered in conjunction with folinic acid and sulfa. The superoxide dismutase 1 gene, which codes for a protein associated with amyotrophic lateral sclerosis, has also been found to be inhibited by pyrimethamine.
What is Pyrimethamine?
Pyrimethamine is a folic acid antagonist that inhibits the dihydrofolate reductase enzyme, disrupting the reproduction of parasites such as Plasmodium (responsible for malaria) and Toxoplasma gondii.
Get free access to sample report @ https://wemarketresearch.c...
Pyrimethamine Market Outlook 2022-2030:
Pyrimethamine Market Growth size was estimated at USD 1,000 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 5.0% to reach approximately USD 1,650 million in 2030. Because pyrimethamine is resistant to many Plasmodium species, it is usually administered in conjunction with folinic acid and sulfa. The superoxide dismutase 1 gene, which codes for a protein associated with amyotrophic lateral sclerosis, has also been found to be inhibited by pyrimethamine.
What is Pyrimethamine?
Pyrimethamine is a folic acid antagonist that inhibits the dihydrofolate reductase enzyme, disrupting the reproduction of parasites such as Plasmodium (responsible for malaria) and Toxoplasma gondii.
Get free access to sample report @ https://wemarketresearch.c...
12:24 PM - Dec 23, 2024 (UTC)